You are here: Industry Insights > acquisition

News List

BMS acquires Celgene for an equity value of $74bn pharmaceutical-technology
January 04, 2019
Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to acquire Celgene via a cash and stock transaction with an equity value of $74bn; Celgene shares have been valued at $102.43 per share.
BMS acquires Celgene for an equity value of $74bn pharmaceutical-technology
January 04, 2019
Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to acquire Celgene via a cash and stock transaction with an equity value of $74bn; Celgene shares have been valued at $102.43 per share....
ResMed to acquire connected inhaler developer Propeller Health for $225M fiercebiotech
January 03, 2019
Former Fierce 15 winner Propeller Health is being acquired by ResMed in a $225 million deal that aims to broaden the reach of its connected respiratory devices to patients across all stages of chronic obstructive pulmonary disease (COPD).....
Aralez completes sale of drug rights to Nuvo Pharmaceuticals for $110m pharmaceutical-technology
January 03, 2019
Canada-based Aralez Pharmaceuticals has completed the divestment of more than 20 medicines under its portfolio to Nuvo Pharmaceuticals for a total consideration of $110m......
Novartis offers to acquire CellforCure cphi-online
January 02, 2019
Proposed acquisition will expand manufacturing capacity for innovative cell and gene therapies.
Boston scientific exercises option to acquire Millipede, Inc. biospectrumasia
January 02, 2019
Boston Scientific Corporation has announced that it exercised its option to acquire the remaining shares of Millipede, Inc, a privately-held company in Santa Rosa, Calif., upon its recent successful completion of a first-in-human clinical study.
Fresenius makes a flurry of deals in Chinese dialysis clinics and hospitals fiercebiotech
December 29, 2018
Fresenius Medical Care has moved to dramatically widen its footprint in China’s dialysis market, acquiring large shares in multiple Chinese companies and hospital systems across the country.....
3P Biopharmaceuticals Completes Facility Expansion contractpharma
December 27, 2018
3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in the process development and GMP production of biologics, has completed the project for the expansion
Roivant strikes broad pipeline pact with Daiichi fiercebiotech
December 25, 2018
Roivant has secured an option to license a stream of drugs from Daiichi Sankyo. The deal is the first time Roivant has formed a framework to facilitate the ongoing in-licensing of drugs from a company rather than picked up assets on an ad hoc basis.....
Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical to Purchase UPSA americanpharmaceuticalreview
December 24, 2018
Bristol-Myers Squibb announced that Taisho Pharmaceutical has offered to purchase Bristol-Myers Squibb’s UPSA consumer health business for $1.6 billion....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page